Position in NTRA
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$1,191,122
+$526,756 QoQ
Shares Held
4,388
+32.1% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#423
of 844 holders
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 20%
Shared 0%
None 80%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Chicago Partners Investment Group LLC holds $14,122,099 across 14 Diagnostics & Research names. NTRA ranks #4 (8.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
13,306 | $2,534,526 | |
| 2 | ILMN |
Illumina, Inc.
|
11,553 | $2,031,363 | |
| 3 | A |
Agilent Technologies, Inc.
|
14,215 | $1,888,178 | |
| 4 | NTRA |
Natera, Inc.
This page
|
4,388 | $1,191,122 | |
| 5 | MEDP |
Medpace Holdings, Inc.
|
1,880 | $995,629 | |
| 6 | TMO |
Thermo Fisher Scientific Inc.
|
1,947 | $976,147 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
5,029 | $971,703 | |
| 8 | IDXX |
Idexx Laboratories Inc /De
|
1,476 | $777,025 |
All Filings in NTRA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,191,122 | 4,388 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $664,366 | 3,322 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $905,821 | 3,954 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $499,328 | 3,102 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $319,127 | 1,889 | Shares | Sole | 2025-07-29 | |
| 2024-12-31 | $297,287 | 1,878 | Shares | Sole | 2025-01-24 | |
| No filing history on record for this holder in this stock. | ||||||